These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 323910

  • 1. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
    Rifkin A, Quitkin F, Kane J, Klein DF.
    Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics.
    Rifkin A, Quitkin F, Rabiner CJ, Klein DF.
    Psychopharmacol Bull; 1976 Apr; 12(2):24-6. PubMed ID: 769022
    [No Abstract] [Full Text] [Related]

  • 3. Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data.
    Rifkin A, Quitkin F, Klein DF.
    Arch Gen Psychiatry; 1977 Oct; 34(10):1215-9. PubMed ID: 199129
    [Abstract] [Full Text] [Related]

  • 4. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G, Annable L, Ross-Chouinard A.
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract] [Full Text] [Related]

  • 5. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 Mar; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 6. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

  • 7. Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year.
    Rifkin A, Quitkin F, Rabiner CJ, Klein DF.
    Arch Gen Psychiatry; 1977 Jan; 34(1):43-7. PubMed ID: 189724
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience with fluphenazine decanoate in the treatment of patients with long-standing chronic schizophrenia.
    Christodoulidis H, Frangos H.
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):193-8. PubMed ID: 809234
    [No Abstract] [Full Text] [Related]

  • 9. A pilot study of "low-dose" fluphenazine decanoate in outpatient schizophrenics [proceedings].
    Kane J, Rifkin A, Quitkin F.
    Psychopharmacol Bull; 1979 Apr; 15(2):78-80. PubMed ID: 373007
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
    Altamura AC, Mauri MC, Girardi T, Panetta B.
    Int J Clin Pharmacol Res; 1990 Apr; 10(4):223-8. PubMed ID: 2079381
    [Abstract] [Full Text] [Related]

  • 11. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ, Doller JC, Schooler NR, Mieske M, Severe J, Mandel MR.
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract] [Full Text] [Related]

  • 12. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W, Boisvert D, Bradwejn J.
    Psychopharmacol Bull; 1984 Feb; 20(1):108-9. PubMed ID: 6371871
    [No Abstract] [Full Text] [Related]

  • 13. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [Abstract] [Full Text] [Related]

  • 14. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 15. [Double-blind study of domestic penfluridol and fluphenazine decanoate].
    Shu L.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Jun; 16(3):141-5. PubMed ID: 6653230
    [No Abstract] [Full Text] [Related]

  • 16. Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
    Granato JE, Stern BJ, Ringel A, Karim AH, Krumholz A, Coyle J, Adler S.
    Ann Neurol; 1983 Jul; 14(1):89-90. PubMed ID: 6614876
    [Abstract] [Full Text] [Related]

  • 17. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Winter K, Fullerton AG, Hussain K, Tarlo L.
    Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
    [No Abstract] [Full Text] [Related]

  • 18. Fluphenazine decanoate: plasma concentrations and clinical response [proceedings].
    Nasrallah HA, Rivera-Calimlin L, Rogol AD.
    Psychopharmacol Bull; 1978 Jul; 14(3):46-7. PubMed ID: 353871
    [No Abstract] [Full Text] [Related]

  • 19. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
    Jayaram G, Coyle J, Tune L.
    J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
    [Abstract] [Full Text] [Related]

  • 20. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 May; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.